August 2025

Balanced Portfolio

High Conviction – Add Telix Pharmaceuticals

As of August 5, 2025 (mid-morning AEST), Telix Pharmaceuticals (TLX) is trading around A$16.84–16.75, down approximately 17% from its previous close of A$20.24. This sharp intraday decline aligns closely with your noted price of $17 (assuming AUD). Below, I’ll address the reasons for this correction based on recent developments and why it still represents a strong buying opportunity to add to positions.

Bulls vs. Bears

Weekend Edition Episode 79: Bull run looking tired despite outstanding MAG7 earnings

In this week’s episode of Bulls vs Bears from MPC Markets, the Mark & Jonathan dive into recent market highlights, commodity trends, stock picks, and geopolitical impacts on trading. They share insights from media appearances, discuss Trump-era tariffs, and provide a bullish outlook for the coming week amid US earnings season. Key focuses include copper, silver, Tesla, and emerging AI influences in markets.

Closing Bell

Closing Bell 1st August: ASX Trims Losses as Miners Rebound Amid Tariff Tensions

The ASX narrowed earlier losses on Friday as a rebound in iron ore prices lifted major miners, despite renewed global trade tensions and inflation concerns. The S&P/ASX 200 was down 71.70 points, or 0.8%, to 8671.10 at 12:10 p.m., recovering from an intraday drop of 1% to 8650.9. The partial recovery followed a modest improvement in S&P 500 futures, which trimmed losses to 0.2%.

Scroll to Top